Protara Therapeutics, Inc. (TARA) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$3,019
Total Return
-69.81%
CAGR
-21.30%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.36% |
| Median | -4.21% |
| Best | +162.60% |
| Worst | -48.91% |
| % of Windows Positive | 40.0% |
1-Year (252 Trading Days)
| Average | +5.25% |
| Median | -10.45% |
| Best | +369.72% |
| Worst | -72.45% |
| % of Windows Positive | 40.3% |
3-Year (756 Trading Days)
| Average | -6.26% |
| Median | -10.61% |
| Best | +171.09% |
| Worst | -83.23% |
| % of Windows Positive | 34.7% |
Risk Metrics
| Maximum Drawdown | -93.38% |
| Average Drawdown | -75.17% |
| Drawdown Duration | 1254 Trading Days (Unrecovered) |
| Sortino Ratio | 0.15 |
| Calmar Ratio | -0.23 |
| CVaR (5%) | -9.63% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -3.75% (-12.57% ann.) | $375.23 | $0.00 | $0.00 | $0.00 |
| 2025 | +0.95% | +$94.70 | $0.00 | $0.00 | $0.00 |
| 2024 | +181.60% | +$18159.96 | $0.00 | $0.00 | $0.00 |
| 2023 | -30.04% | $3003.75 | $0.00 | $0.00 | $0.00 |
| 2022 | -60.30% | $6029.61 | $0.00 | $0.00 | $0.00 |
| 2021 | -72.12% | $7211.90 | $0.00 | $0.00 | $0.00 |
| 2020 | +47.62% | +$4762.20 | $0.00 | $0.00 | $0.00 |
| 2019 partial | -18.16% (-23.15% ann.) | $1816.37 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | March 28, 2019 – February 19, 2020 | +82.98% | +95.98% | +$8298.40 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -39.60% | -99.68% | $3959.77 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -21.00% | -31.56% | $2100.00 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -65.72% | -63.78% | $6571.99 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -64.73% | -66.93% | $6473.16 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -26.91% | -15.56% | $2690.76 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +167.19% | +87.10% | +$16718.85 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.